Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LUCENTIS Cause Polypoidal choroidal vasculopathy? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Polypoidal choroidal vasculopathy have been filed in association with LUCENTIS. This represents 0.9% of all adverse event reports for LUCENTIS.

6
Reports of Polypoidal choroidal vasculopathy with LUCENTIS
0.9%
of all LUCENTIS reports
0
Deaths
0
Hospitalizations

How Dangerous Is Polypoidal choroidal vasculopathy From LUCENTIS?

Of the 6 reports.

Is Polypoidal choroidal vasculopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LUCENTIS. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does LUCENTIS Cause?

Death (138) Visual acuity reduced (98) Vision blurred (64) Cerebrovascular accident (54) Off label use (54) Eye pain (43) Visual impairment (43) Vitreous floaters (42) Blindness (34) Drug ineffective (33)

What Other Drugs Cause Polypoidal choroidal vasculopathy?

RANIBIZUMAB (153) VERTEPORFIN (128) AFLIBERCEPT (44) BROLUCIZUMAB-DBLL (10) BEVACIZUMAB (5)

Which LUCENTIS Alternatives Have Lower Polypoidal choroidal vasculopathy Risk?

LUCENTIS vs LUCRIN DEPOT LUCENTIS vs LUMASIRAN LUCENTIS vs LUMATEPERONE LUCENTIS vs LUMIGAN LUCENTIS vs LUPRON DEPOT

Related Pages

LUCENTIS Full Profile All Polypoidal choroidal vasculopathy Reports All Drugs Causing Polypoidal choroidal vasculopathy LUCENTIS Demographics